- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT02503917
Gynaecologic Organ Segmentation and Motion Tracking Using Ultrasound (GENIUS)
Przegląd badań
Status
Warunki
Szczegółowy opis
Radiotherapy is an established and effective method for treating cancer, but it can have negative side effects if healthy tissues are also exposed to radiation. In the case of cervical cancer, the bladder, small bowel, and bone marrow are often irradiated, which can result in both short-term and long-term side effects. There are sophisticated radiation delivery techniques (known as IMRT and VMAT) which are capable of administering the radiation dose in a precise and controlled manner so that the intended target is irradiated and the healthy tissue is spared. However, the only way for these sophisticated radiation delivery methods to work in cervical cancer is to localise the uterus prior to radiotherapy treatment so that the lineup between the radiation beam and the target is ensured. The uterus is a relatively mobile organ, and can have very different positions within the body depending on the patient position, bladder volume, tumour site, etc. Currently, we are unable to take advantage of the sophisticated radiation delivery techniques as we have no reliable way of seeing where the uterus is. Ultrasound is a promising way to overcome this problem.
Ultrasound is non-ionising, has good soft-tissue contrast, and can easily be incorporated into the radiation treatment room. We wish to establish the feasibility and accuracy of localising and outlining the uterus on ultrasound images. This will enable us to determine whether or not ultrasound will be a good option to ensure the correct patient position prior to radiotherapy for cervical cancer patients.
Typ studiów
Zapisy (Oczekiwany)
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Surrey
-
Sutton, Surrey, Zjednoczone Królestwo, SM2 5PT
- Rekrutacyjny
- Royal Marsden Hospital NHS Foundation Trust
-
Kontakt:
- Julie Curtis
- Numer telefonu: 02086713873
- E-mail: julie.curtis@rmh.nhs.uk
-
Pod-śledczy:
- Sarah Mason
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Metoda próbkowania
Badana populacja
Opis
Inclusion Criteria:
- healthy volunteer cohort: Healthy female adult volunteers
- patient volunteer cohort: Patients receiving radiotherapy for cervical cancer who will receive a planning CT scan and daily CBCT scanning as part of their treatment.
Exclusion Criteria:
- both cohorts: Women who have received hysterectomies and women who are pregnant at the time of the study
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Modele obserwacyjne: Kohorta
- Perspektywy czasowe: Spodziewany
Kohorty i interwencje
Grupa / Kohorta |
|---|
|
Healthy volunteers
Healthy female adult volunteers
|
|
Cervical cancer patients
Patients receiving radiotherapy for cervical cancer at the Royal Marsden who will receive a planning CT scan and daily CBCT scanning as part of their treatment.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Percentage of ultrasound scans with dice similarity coefficient (DSC) of >0.90 between algorithm-derived contour and ground-truth contour
Ramy czasowe: DSC calculated at 24 time points for each healthy volunteer (3 days)
|
The DSC between the ground truth contour and the algorithm derived contour will indicate the accuracy of the segmentation algorithm.
|
DSC calculated at 24 time points for each healthy volunteer (3 days)
|
|
Coefficient of variation between of expert-drawn contours on ultrasound and expert-drawn contours on CBCT
Ramy czasowe: COV calculated at a minimum of 3 time points during 6 weeks that the patient is receiving radiation therapy
|
A small COV will indicate greater clinician/expert confidence in segmenting the uterus
|
COV calculated at a minimum of 3 time points during 6 weeks that the patient is receiving radiation therapy
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Bland-Altman plot (healthy volunteer cohort)
Ramy czasowe: 1 day
|
Used to describe the level of agreement between MR and ultrasound images of the uterus.
|
1 day
|
|
Uterine center of mass displacement on ultrasound (healthy volunteer cohort)
Ramy czasowe: 3 days
|
Assess both inter- and intra- fractional motion of the uterus.
|
3 days
|
|
Expert confidence scores for each imaging modality (ultrasound and MR) (healthy volunteer cohort)
Ramy czasowe: from data collected over 3 days
|
Determine if uterine segmentation on ultrasound receives acceptable confidence score compared with MR
|
from data collected over 3 days
|
|
Bland-Altman plot (patient volunteer cohort)
Ramy czasowe: 6 weeks
|
describe level of agreement among the COV, circularity index, volume, and centre of mass position betweeen ultrasound, CT, and CBCT.
|
6 weeks
|
|
Expert confidence scores for each imaging modality (ultrasound, CT, and CBCT) (patient volunteer cohort)
Ramy czasowe: from data collected over 6 weeks
|
Determine if uterine segmentation on ultrasound receives greater confidence score compared with CT and CBCT.
|
from data collected over 6 weeks
|
Współpracownicy i badacze
Współpracownicy
Śledczy
- Główny śledczy: Susan Lalondrelle, Royal Marsden Hospital NHS Foundation Trust
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów
Zakończenie podstawowe (Oczekiwany)
Ukończenie studiów (Oczekiwany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Oszacować)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- CCR4342
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .